Patient Safety Organizations: Voluntary Relinquishment for the QCMetrix PSO, 14014-14015 [2022-05163]
Download as PDF
14014
Federal Register / Vol. 87, No. 48 / Friday, March 11, 2022 / Notices
• More comprehensive insurance
coverage
• Extended duration of insurance
coverage
• More continuous insurance coverage
• Better/more continuous access to care
as the result of a targeted program
at the state, system, or provider
level (e.g., Medicaid expansion)
term ill health
Æ Physical health/medical outcomes
D Postpartum onset of preeclampsia
or hypertension
D Infections (e.g., mastitis, wound
infections)
D Severe maternal morbidity
Æ Cardiovascular disorders (e.g.,
cardiomyopathy)
Æ Cerebrovascular disorders (e.g.,
stroke)
Æ Bleeding
Æ Venous thromboembolism
Æ Other
Æ Interpregnancy interval
Æ Unintended pregnancies
Æ Contraceptive initiation and
continuation
Æ Breastfeeding intention, initiation,
duration, and exclusivity
Æ Reduction in health inequities (e.g.,
by race, ethnicity, geography,
disability status)
• Harms
Æ Health inequities *
Æ Perceived discrimination *
Æ Over-utilization of healthcare
Æ Patient burden regarding
postpartum care
Comparators
Potential Effect Modifiers
• Less comprehensive level of or no
insurance coverage
• Less continuous insurance coverage
• Worse, less continuous, or no access
to healthcare
Outcomes (* and bold font denotes
important outcomes that will be used
when developing Strength of Evidence
tables)
• Intermediate and healthcare
utilization outcomes
Æ Attendance at postpartum visits *
Æ Unplanned care utilization (e.g.,
readmissions, emergency room
visits) *
Æ Adherence to condition-specific
screening/testing (e.g., blood
pressure monitoring, glucose
tolerance testing) or treatment *
Æ Transition to primary care provider
for long-term care *
• Clinical outcomes (as appropriate,
outcomes include incidence,
prevalence/continuation, severity,
and resolution)
Æ Maternal mortality *
Æ Symptoms or diagnosis of mental
health conditions (e.g., anxiety,
depression, substance use) *
Æ Patient-reported outcomes
D Quality of life (using validated
measures) *
D Perceived stress *
D Pain
D Sleep quality
D Fatigue
D Sexual well-being and satisfaction
D Awareness of risk factors for long-
• Patient-level factors
Æ Age
Æ Race/ethnicity
Æ Gender identity
Æ Sexual identity
Æ Physical disability status
Æ Socioeconomic status
Æ Immigration status
Æ Barriers to transportation to
healthcare facility
Æ Paid family leave policies (e.g.,
presence versus absence, different
durations of leave)
Æ Substance use/substance use
disorder
Æ Type of insurance coverage
(insured versus uninsured, private
versus public [e.g., Medicaid],
insurance coverage of postpartum
care, Medicaid insurance coverage
extension or expansion)
Æ Presence versus absence of
disorders of pregnancy (e.g.,
hypertensive, cardiovascular,
gestational diabetes mellitus) or
peripartum complications that
increase risk of postpartum
complications
Æ Preterm versus term delivery
Æ Live birth versus stillbirth/
spontaneous abortion/induced
abortion
Æ Number of infants (singleton versus
twins/triplets, etc.)
Æ Presence versus absence of a
supportive partner
Æ Infant health (e.g., neonatal
intensive care unit [NICU]
postpartum depression, new-onset
diabetes)
• Exclude:
Æ Individuals with specific health
conditions not typically managed
by providers of pregnancy and
postpartum care, (e.g., multiple
sclerosis, HIV, cancer, substance
use disorders other than tobacco).
Æ Individuals with diagnosed chronic
conditions—pre-existing (nongestational) diabetes, cardiac
disease/risk factors (e.g.,
cardiomyopathy, pre-existing [nongestational] hypertension), mood
disorders (e.g., major depression,
anxiety), stress urinary
incontinence, and dyspareunia.
lotter on DSK11XQN23PROD with NOTICES1
Interventions
VerDate Sep<11>2014
17:10 Mar 10, 2022
Jkt 256001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
admission, congenital anomalies)
• Setting factors
Æ Geographic location (urban versus
suburban versus rural)
Æ Different levels of neighborhood
vulnerability (e.g., social
vulnerability index)
Æ Volume of facility/hospital (high
versus low)
Æ Type of facility/hospital (private
versus public)
Æ Racial/ethnic concordance between
provider and patient
Æ Language concordance between
provider and patient
Timing
• Interventions and Comparators:
Within 1 year after giving birth
• Outcome measurement: Up to 1 year
after giving birth (except
interpregnancy interval, unintended
pregnancies, and chronic diseases
[e.g., diabetes, hypertension], which
can be later)
Settings
• U.S. only
• Outpatient care
• Exclude: Institutionalized settings
(e.g., prisons)
Design
• Randomized controlled trials (N
≥10 participants per group)
• Nonrandomized comparative
studies, longitudinal (prospective or
retrospective) or cross-sectional (N
≥30 participants per group)
• Case-control studies (N ≥30
participants per group)
• Exclude: Single-group
(noncomparative) studies,
comparative cross-sectional studies
(without a discernable time-period
between intervention and
measurement of outcomes),
qualitative studies
Dated: March 7, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–05141 Filed 3–10–22; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment for the
QCMetrix PSO
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of delisting.
AGENCY:
E:\FR\FM\11MRN1.SGM
11MRN1
Federal Register / Vol. 87, No. 48 / Friday, March 11, 2022 / Notices
The Patient Safety and
Quality Improvement Final Rule
(Patient Safety Rule) authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a patient safety organization (PSO) an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient
Safety Rule, when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason, or when a PSO’s
listing expires. AHRQ accepted a
notification of proposed voluntary
relinquishment from the QCMetrix PSO,
PSO number P0166, of its status as a
PSO, and has delisted the PSO
accordingly.
DATES: The delisting was effective at
12:00 Midnight ET (2400) on February
11, 2022.
ADDRESSES: The directories for both
listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. Both
directories can be accessed
electronically at the following HHS
website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
Background
The Patient Safety Act, 42 U.S.C.
299b–21 to 299b–26, and the related
Patient Safety Rule, 42 CFR part 3,
published in the Federal Register on
November 21, 2008 (73 FR 70732–
70814), establish a framework by which
individuals and entities that meet the
definition of provider in the Patient
Safety Rule may voluntarily report
information to PSOs listed by AHRQ, on
a privileged and confidential basis, for
the aggregation and analysis of patient
safety work product.
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
VerDate Sep<11>2014
17:10 Mar 10, 2022
Jkt 256001
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
PSOs.
AHRQ has accepted a notification of
proposed voluntary relinquishment
from the QCMetrix PSO to voluntarily
relinquish its status as a PSO.
Accordingly, the QCMetrix PSO, PSO
number P0166, was delisted effective at
12:00 Midnight ET (2400) on February
11, 2022.
QCMetrix PSO has patient safety work
product (PSWP) in its possession. The
PSO will meet the requirements of
section 3.108(c)(2)(i) of the Patient
Safety Rule regarding notification to
providers that have reported to the PSO
and of section 3.108(c)(2)(ii) regarding
disposition of PSWP consistent with
section 3.108(b)(3). According to section
3.108(b)(3) of the Patient Safety Rule,
the PSO has 90 days from the effective
date of delisting and revocation to
complete the disposition of PSWP that
is currently in the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO website
at https://www.pso.ahrq.gov.
Dated: March 7, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–05163 Filed 3–10–22; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Plan for Foster Care and
Adoption Assistance—Title IV–E (OMB
#0970–0433)
Children’s Bureau,
Administration for Children and
Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Children’s Bureau (CB),
Administration for Children and
Families (ACF), U.S. Department of
Health and Human Services (HHS), is
requesting a 3-year extension of the Plan
for Foster Care and Adoption
Assistance—Title IV–E, (OMB#: 0970–
SUMMARY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
14015
0433, expiration 11/30/2022). This plan
also incorporates the plan requirements
for the optional Guardianship
Assistance Program, the Title IV–E
prevention services plan and the Title
IV–E Kinship Navigator program. There
are no changes requested to the form.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of the Paperwork
Reduction Act of 1995, ACF is soliciting
public comment on the specific aspects
of the information collection described
above.
ADDRESSES: You can obtain copies of the
proposed collection of information and
submit comments by emailing
infocollection@acf.hhs.gov. Identify all
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: A title IV–E plan is
required by section 471, Part IV–E of the
Social Security Act (the Act) for each
public child welfare agency requesting
federal funding for foster care, adoption
assistance, and guardianship assistance
under the Act. Section 479B of the Act
provides for an Indian tribe, tribal
organization, or tribal consortium (tribe)
to operate a title IV–E program in the
same manner as a state with minimal
exceptions. The tribe must have an
approved Title IV–E Plan. The Title IV–
E Plan provides assurances the
programs will be administered in
conformity with the specific
requirements stipulated in Title IV–E.
The plan must include all applicable
state or tribal statutory, regulatory, or
policy references and citations for each
requirement as well as supporting
documentation. A title IV–E agency may
use the pre-print format prepared by CB,
or a different format, on the condition
that the format used includes all of the
Title IV–E Plan requirements.
Title IV–E of the Act was amended by
Public Law 115–123, which included
the Family First Prevention Services Act
(FFPSA). FFPSA authorized new
optional Title IV–E funding for timelimited (1 year) prevention services for
mental health/substance abuse and inhome parent skill-based programs for (1)
a child who is a candidate for foster care
(as defined in section 475(13) of the
Act), (2) pregnant/parenting foster
youth, and (3) the parents/kin caregivers
of those children and youth (sections
471(e), 474(a)(6), and 475(13) of the
Act). Title IV–E prevention services
must be rated as promising, supported,
or well supported in accordance with
HHS criteria and be approved by HHS
(section 471(e)(4)(C) of the Act) as part
of the Title IV–E Prevention Services
Clearinghouse (section 476(d)(2) of the
E:\FR\FM\11MRN1.SGM
11MRN1
Agencies
[Federal Register Volume 87, Number 48 (Friday, March 11, 2022)]
[Notices]
[Pages 14014-14015]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05163]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment for the
QCMetrix PSO
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
[[Page 14015]]
SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient
Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to
list as a patient safety organization (PSO) an entity that attests that
it meets the statutory and regulatory requirements for listing. A PSO
can be ``delisted'' by the Secretary if it is found to no longer meet
the requirements of the Patient Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses
to voluntarily relinquish its status as a PSO for any reason, or when a
PSO's listing expires. AHRQ accepted a notification of proposed
voluntary relinquishment from the QCMetrix PSO, PSO number P0166, of
its status as a PSO, and has delisted the PSO accordingly.
DATES: The delisting was effective at 12:00 Midnight ET (2400) on
February 11, 2022.
ADDRESSES: The directories for both listed and delisted PSOs are
ongoing and reviewed weekly by AHRQ. Both directories can be accessed
electronically at the following HHS website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
(301) 427-1130; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the
related Patient Safety Rule, 42 CFR part 3, published in the Federal
Register on November 21, 2008 (73 FR 70732-70814), establish a
framework by which individuals and entities that meet the definition of
provider in the Patient Safety Rule may voluntarily report information
to PSOs listed by AHRQ, on a privileged and confidential basis, for the
aggregation and analysis of patient safety work product.
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of PSOs.
AHRQ has accepted a notification of proposed voluntary
relinquishment from the QCMetrix PSO to voluntarily relinquish its
status as a PSO. Accordingly, the QCMetrix PSO, PSO number P0166, was
delisted effective at 12:00 Midnight ET (2400) on February 11, 2022.
QCMetrix PSO has patient safety work product (PSWP) in its
possession. The PSO will meet the requirements of section
3.108(c)(2)(i) of the Patient Safety Rule regarding notification to
providers that have reported to the PSO and of section 3.108(c)(2)(ii)
regarding disposition of PSWP consistent with section 3.108(b)(3).
According to section 3.108(b)(3) of the Patient Safety Rule, the PSO
has 90 days from the effective date of delisting and revocation to
complete the disposition of PSWP that is currently in the PSO's
possession.
More information on PSOs can be obtained through AHRQ's PSO website
at https://www.pso.ahrq.gov.
Dated: March 7, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022-05163 Filed 3-10-22; 8:45 am]
BILLING CODE 4160-90-P